PGLa
CAS No. 102068-15-5
PGLa ( )
Catalog No. M30471 CAS No. 102068-15-5
PGLa is a cationic antimicrobial peptide (AMP) originally isolated from frog. It has been shown to have antibacterial,antifungal,and antiviral,activities.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 988 | Get Quote |
|
100MG | Get Quote | Get Quote |
|
200MG | Get Quote | Get Quote |
|
500MG | Get Quote | Get Quote |
|
Biological Information
-
Product NamePGLa
-
NoteResearch use only, not for human use.
-
Brief DescriptionPGLa is a cationic antimicrobial peptide (AMP) originally isolated from frog. It has been shown to have antibacterial,antifungal,and antiviral,activities.
-
DescriptionPGLa is a cationic antimicrobial peptide (AMP) originally isolated from frog. It has been shown to have antibacterial,antifungal,and antiviral,activities. (In Vitro):PGLa is a peptide starting with a glycine and ending with a leucine amide. PGLa is bacteriostatic against both Gram-positive and Gram-negative bacteria with MIC values of 64 and 32 mg/L against S. aureus and E. coli, respectively.
-
Synonyms
-
PathwayGPCR/G Protein
-
TargetAntibacterial
-
RecptorAnti-bacteria
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number102068-15-5
-
Formula Weight1968.5
-
Molecular FormulaC88H162N26O22S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical Name
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
Bechinger B, et al. Structure and dynamics of the antibiotic peptide PGLa in membranes by solution and solid-state nuclear magnetic resonance spectroscopy. Biophys J. 1998 Feb;74(2 Pt 1):981-7.
molnova catalog
related products
-
Erythromycin
Erythromycin, an oral macrolide antibiotic produced by Streptomyces erythreus, reversibly binds to the 50S ribosome of bacteria, and inhibits protein synthesis.
-
LL-3858 dihydrchlori...
A novel anti-TB agent that has an MIC range of 0.06-0.5 ug/mL.
-
Cefamandole nafate
Cefamandole nafate is a second-generation broad-spectrum cephalosporin antibiotic.